Literature DB >> 6199454

Production of plasminogen activator by human natural killer cells. Large granular lymphocytes.

R H Goldfarb, T Timonen, R B Herberman.   

Abstract

In this report we have used highly purified populations of natural killer (NK) cells: large granular lymphocytes (LGL). This study demonstrates that freshly isolated and interleukin 2-cultured LGL produce the specific neutral serine protease, plasminogen activator (PA). We have found that the enzyme is expressed in both an extracellular form as well as in a cell-associated form. Upon subcellular distribution the latter form of the enzyme is associated with a cell-surface membrane-enriched fraction. LGL PA exists in multiple molecular weight forms ranging from 100,000 to 26,000. Interferon (IFN), the major positive regulator of NK cytolytic activity, caused a substantial enhancement of cell-associated, but not extracellular, PA. In contrast, LGL isolated from patients with Chediak-Higashi syndrome, who are known to be defective in NK activity, displayed low PA activity, altered morphology, and low NK killing relative to LGL isolated from normal donors. The possible role of LGL PA in the lysis of tumor cells by NK cells, either directly or indirectly, is discussed.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6199454      PMCID: PMC2187254          DOI: 10.1084/jem.159.3.935

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  33 in total

1.  Proteolytic activity determined with a substrate tagged with radioactive iodine.

Authors:  N R SHULMAN; H J TAGNON
Journal:  J Biol Chem       Date:  1950-09       Impact factor: 5.157

2.  Direct fluorescent assay of urokinase and plasminogen activators of normal and malignant cells: kinetics and inhibitor profiles.

Authors:  M Zimmerman; J P Quigley; B Ashe; C Dorn; R Goldfarb; W Troll
Journal:  Proc Natl Acad Sci U S A       Date:  1978-02       Impact factor: 11.205

Review 3.  Synergistic effect of tumor virus transformation and tumor promoter treatment on the production of plasminogen activator by chick embryo fibroblasts.

Authors:  R H Goldfarb; J P Quigley
Journal:  Cancer Res       Date:  1978-12       Impact factor: 12.701

4.  Fibrinolysis associated with oncogenic transformation. Partial purification and characterization of the cell factor, a plasminogen activator.

Authors:  J Unkeless; K Dano; G M Kellerman; E Reich
Journal:  J Biol Chem       Date:  1974-07-10       Impact factor: 5.157

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Target-effector interaction in the natural killer (NK) cell system. II. The isolation of NK cells and studies on the mechanism of killing.

Authors:  J C Roder; R Kiessling; P Biberfeld; B Andersson
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

7.  A cytotoxic proteinase isolated from human lymphocytes.

Authors:  V B Hatcher; M S Oberman; G S Lazarus; A I Grayzel
Journal:  J Immunol       Date:  1978-02       Impact factor: 5.422

8.  The susceptibility of urokinase to affinity labeling by peptides of arginine chloromethyl ketone.

Authors:  C Kettner; E Shaw
Journal:  Biochim Biophys Acta       Date:  1979-07-11

9.  Association of a protease (plasminogen activator) with a specific membrane fraction isolated from transformed cells.

Authors:  J P Quigley
Journal:  J Cell Biol       Date:  1976-11       Impact factor: 10.539

10.  Specific protease deficiency in polymorphonuclear leukocytes of Chédiak-Higashi syndrome and beige mice.

Authors:  J D Vassalli; A Granelli-Piperno; C Griscelli; E Reich
Journal:  J Exp Med       Date:  1978-04-01       Impact factor: 14.307

View more
  6 in total

1.  Chédiak-Higashi syndrome neutrophils are characterized by the absence of both normal azurophilic granules.

Authors:  B C West
Journal:  Am J Pathol       Date:  1986-01       Impact factor: 4.307

2.  Induction of DNA synthesis in isolated nuclei by cytoplasmic factors: inhibition by protease inhibitors.

Authors:  R L Wong; J K Gutowski; M Katz; R H Goldfarb; S Cohen
Journal:  Proc Natl Acad Sci U S A       Date:  1987-01       Impact factor: 11.205

3.  Involvement of cell surface macromolecules sensitive to alkylating ketones in lysis by human peripheral blood NK cells.

Authors:  M M Dawson; U Shipton; M Moore
Journal:  Clin Exp Immunol       Date:  1985-01       Impact factor: 4.330

4.  Inhibition of natural killer cell-mediated cytotoxicity by lipids extracted from Mycobacterium bovis BCG.

Authors:  R C Roozemond; M Halperin; P K Das
Journal:  Clin Exp Immunol       Date:  1985-12       Impact factor: 4.330

5.  Matrix metalloproteinases in cytotoxic lymphocytes impact on tumour infiltration and immunomodulation.

Authors:  Karin Edsparr; Per H Basse; Ronald H Goldfarb; Per Albertsson
Journal:  Cancer Microenviron       Date:  2010-11-27

6.  Production of plasminogen activators by human T-cell leukaemia virus-transformed human T cell lines.

Authors:  S Hinuma; S Honda; K Tsukamoto; K Sugamura; Y Hinuma
Journal:  Br J Cancer       Date:  1985-06       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.